Cannabidiol and cardiovascular diseases: New hope for cardiac medicine?

Research around cannabidiol (CBD) is developing rapidly. While CBD has so far been mainly associated with the treatment of pain, anxiety disorders, or epilepsy, a new area of application is now coming into focus: cardiovascular medicine. A current scientific review examines whether CBD could play a role in the treatment of cardiovascular diseases in the future. The results show: The non-intoxicating cannabinoid possesses remarkable anti-inflammatory, antioxidant, and vasodilatory properties that could have a positive effect on various heart diseases. However, the research is still in its early stages.

Why could CBD be interesting for the heart?

Unlike THC, CBD does not have psychoactive effects. Instead, it influences numerous biological signaling pathways that are important for heart health.

The researchers identify three particularly important mechanisms of action:

• Anti-inflammatory effects
• Antioxidant effects
• Improvement of vascular function

Chronic inflammation and oxidative stress are now considered central causes of many cardiovascular diseases. CBD could therapeutically target exactly these points.

CBD in pericarditis (inflammation of the heart sac)

The results are particularly promising in recurrent pericarditis, i.e., recurring inflammation of the heart sac.

Animal studies show clear effects

In animal models, CBD reduced:

• the thickness of the pericardium,
• the accumulation of fluid in the pericardium,
• the production of pro-inflammatory mediators such as IL-1β and IL-6.

These results suggest that CBD can specifically influence inflammatory processes in the heart.

First clinical studies give hope

In the phase II study MAVERIC-Pilot, patients with recurrent pericarditis received a highly purified CBD preparation. The result:

• significant reduction of pain,
• rapid symptom improvement within a few days,
• good tolerability.

If ongoing studies confirm these results, CBD could in the future represent a non-immunosuppressive alternative to cortisone or IL-1 inhibitors.

Can CBD alleviate myocarditis?

Scientists also see great potential in myocarditis, an inflammation of the heart muscle.

Less inflammation and less scarring

In preclinical studies, CBD led to:

• reduced inflammation of the heart muscle,
• less fibrosis,
• improved heart function.

Since treatment options for myocarditis are limited, new therapeutic approaches may be urgently needed. The clinical study ARCHER is currently investigating whether these positive effects can also be confirmed in humans.

CBD as protection against heart attack damage?

The data on so-called ischemia-reperfusion injury are particularly exciting.

The problem after a heart attack

If a blocked coronary artery is reopened, the sudden restoration of blood flow can cause additional damage. Inflammation and free radicals play a decisive role in this.

CBD reduces infarct size

In animal studies, CBD was able to:

• reduce the infarct size by up to 66 percent,
• improve blood flow,
• significantly attenuate inflammatory reactions.

Researchers also found indications of a protective effect on the small blood vessels of the heart. However, clinical studies in humans confirming these results are still lacking.

Potential in heart failure and cardiomyopathies

Chronic heart failure often arises from:

• heart attacks,
• diabetes,
• inflammation,
• oxidative stress.

These are exactly the mechanisms influenced by CBD.

Protection of heart muscle cells

In various animal models, CBD showed:

• less cell damage,
• reduced fibrosis,
• better pumping function of the heart.

The results are particularly interesting in:

Diabetic cardiomyopathy

Here, CBD reduced:

• oxidative stress,
• inflammatory processes,
• mitochondrial damage.

Chemotherapy-induced heart damage

CBD also showed a significant protective effect against heart damage caused by chemotherapy drugs. Whether these effects are transferable to humans remains to be clarified by future studies.

Can CBD lower blood pressure?

Another research area is the effect of CBD on hypertension.

Clinical study shows positive results

In a randomized study with patients with mild to moderate hypertension, taking CBD led to:

• lower systolic blood pressure values,
• lower diastolic values,
• an improvement in the 24-hour blood pressure profile.

The blood pressure reduction was moderate but could nevertheless be clinically relevant in the long term.

Researchers suspect that, in addition to vasodilatory effects, the anxiolytic properties of CBD also play a role.

Are there risks for the heart?

Despite the promising results, the authors warn against premature use.

Conclusion: Does CBD have a future in cardiology?

The new review paints a promising picture. CBD could in the future play a role in:

• Pericarditis
• Myocarditis
• Heart failure
• Ischemic heart diseases
• Hypertension

Its anti-inflammatory and antioxidant properties make the active ingredient an exciting candidate for cardiovascular medicine. Nevertheless, the current data are still insufficient to recommend CBD as a standard therapy for cardiovascular diseases. Only large, randomized studies will have to show whether the promising results from laboratory and animal models can also be confirmed in humans. Until then, cannabidiol remains an extremely interesting field of research – with the potential to fundamentally change the future treatment of certain heart diseases.

Sources:
Abdalla HM, Bacon A, VanDolah H et al. Cannabidiol in Cardiovascular Disease: A Review of Current Evidence and Future Directions. Journal of Cardiovascular Pharmacology and Therapeutics, 2026. DOI: 10.1016/j.mayocp.2025.10.009
Martinez-Naya N et al. Cannabidiol reduces inflammation in experimental acute pericarditis.
MAVERIC-Pilot Trial – Impact of CardiolRx™ on Recurrent Pericarditis.
ARCHER Trial – Acute Myocarditis Cannabidiol Therapy Study

Images: National Cancer Institute on Unsplash